Inhibikase Therapeutics Total Shareholders Equity 2011-2026 | IKT

Annual Total Shareholders Equity Inhibikase Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
173 M	94.9 M	11 M	21 M	38.4 M	9.78 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
173 M	9.78 M	58 M

Quarterly Total Shareholders Equity Inhibikase Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
72.9 M	80.1 M	85.7 M	94.9 M	-531 K	5.1 M	6.78 M	11 M	15 M	19.5 M	25.3 M	21 M	25.1 M	29.5 M	34 M	38.4 M	43.2 M	47.1 M	8.04 M	9.78 M	9.78 M	9.78 M	9.78 M	-4.49 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
94.9 M	-4.49 M	29 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	35.5 M	$ 3.97	6.43 %	$ 9.55 B	Australia
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
AlloVir ALVR	78.8 M	-	4.14 %	$ 49.1 M	USA
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Akari Therapeutics, Plc AKTX	28.3 M	$ 5.12	11.55 %	$ 345 B	Britain
Aligos Therapeutics ALGS	53.5 M	$ 7.66	3.23 %	$ 75.7 M	USA
Allakos ALLK	169 M	-	-	$ 28.6 M	USA
Alnylam Pharmaceuticals ALNY	789 M	$ 320.13	-3.98 %	$ 41.9 B	USA
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Amphastar Pharmaceuticals AMPH	789 M	$ 21.81	0.6 %	$ 1.02 B	USA
Burford Capital Limited BUR	1.7 B	$ 4.67	-1.37 %	$ 766 M	Britain
Applied Therapeutics APLT	-17.1 M	-	-	$ 8.42 M	USA
BioNTech SE BNTX	1.37 B	$ 102.12	2.66 %	$ 27.2 B	Germany
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	5.59 M	$ 3.08	-4.94 %	$ 5.07 M	Israel
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	32.6 M	$ 1.35	-12.9 %	$ 347 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	-33.7 M	$ 4.26	0.47 %	$ 456 M	USA
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Arcutis Biotherapeutics ARQT	189 M	$ 24.19	-1.59 %	$ 3.08 B	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Brainstorm Cell Therapeutics BCLI	-9.98 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	188 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	178 M	$ 1.61	8.05 %	$ 428 M	Britain
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
BeiGene, Ltd. BGNE	4.36 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	195 M	-	-	$ 546 M	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Cidara Therapeutics CDTX	163 M	-	-	$ 1.41 B	USA
BioXcel Therapeutics BTAI	-95.5 M	$ 1.07	1.9 %	$ 13.1 M	USA
Cabaletta Bio CABA	112 M	$ 3.52	3.53 %	$ 354 M	USA
CymaBay Therapeutics CBAY	292 M	-	-	$ 3.45 B	USA
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
ChromaDex Corporation CDXC	76.5 M	-	-0.88 %	$ 598 M	USA